AFP and hepatocellular carcinoma: For example, Matboli et al. [45] reported that the EV lncRNA-P11-583F2.2 showed higher sensitivity and specificity (96.7%, 91.7%) than AFP (90%, 85%) in diagnosing HCC, and lncRNA JPX had a sensitivity of 91.5% and specificity of 72.7%.